Cardinal Health, Inc.
NYSE:CAHMedical - Distribution
-$3.77 today
- Market cap
- $64.33B
- Beta
- 0.53
- P/E (TTM)
- 33.5
- EPS (TTM)
- $6.63
- Dividend yield
- 0.92%
Volume 1.35M
Average 2.11M
CAH Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Cardinal Health, Inc.NYSE: CAH
Cash & Equivalents · Q1 FY2027 · quarter ended Sep 2026
Cash & equivalents rises 14.6% from a year ago
Cash & equivalents stood at $5.26B at the end of Q1 FY2027, up 14.6% from a year earlier and up 8.4% from the prior quarter. Over 3 fiscal years it compounded at +6.0% a year.
Context
- Cash & equivalents amounted to 8.8% of total assets at the end of Q1 FY2027, up 0.5 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +14.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2026
- 4.86B USD
- Year-over-year change
- +25.3%
- 4-year CAGR
- +0.7%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2026 | 2026-06-30 | 4.86B | +25.3% |
| FY2025 | 2025-06-30 | 3.87B | -24.5% |
| FY2024 | 2024-06-30 | 5.13B | +25.9% |
| FY2023 | 2023-06-30 | 4.08B | -13.6% |
| FY2022 | 2022-06-30 | 4.72B | — |
Cash & Equivalents vs competitors
How CAH compares with its peers on the latest reported figures
- CAH's Sep 2026 cash & equivalents of $5.26B is the highest of the 4 companies compared; the peer median is $2.82B.
- Its year-over-year change of +14.6% is the 3rd highest of 4, against a peer median of +23.7%.
- Cash & equivalents amounts to 8.8% of total assets for CAH, versus a peer median of 3.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $5.26B | +14.6% | +6.0% | 8.8% | |
| Jun 2026 | $5.16B | +113.6% | -5.3% | 5.8% | |
| Jun 2026 | $2.82B | +23.7% | +7.5% | 3.4% | |
| Jun 2026 | $157M | +8.3% | +10.1% | 1.4% | |
| Peer median (excluding CAH) | $2.82B | +23.7% | +7.5% | 3.4% | |
Competitors are the stored peer set for CAH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 | FY2026 Jun 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 4.72B | 4.08B | 5.13B | 3.87B | 4.86B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 10.57B | 11.11B | 12.08B | 13.24B | 13.82B |
| Inventory | 15.64B | 16.12B | 14.96B | 16.83B | 17.3B |
| Other Current Assets | 36M | 72M | 2.71B | 2.43B | 21M |
| Total Current Assets | 32.94B | 33.74B | 34.88B | 36.37B | 38.75B |
| Property, Plant & Equipment (Net) | 2.36B | 2.46B | 2.53B | 2.86B | 4.02B |
| Goodwill | 5.86B | 4.61B | 4.73B | 9.69B | 11.44B |
| Intangible Assets | 1.77B | 1.47B | 1.73B | 2.49B | 2.19B |
| Long-term Investments | 77M | 56M | 43M | 14M | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 876M | 1.01B | 1.22B | 1.7B | 893M |
| Total Non-current Assets | 10.94B | 9.61B | 10.24B | 16.75B | 18.55B |
| Total Assets | 43.88B | 43.35B | 45.12B | 53.12B | 57.3B |
| Account Payables | 27.13B | 29.93B | 31.76B | 34.71B | 38.28B |
| Short-term Debt | 682M | 892M | 551M | 714M | 1.84B |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 42M | 0 | (164M) | 0 |
| Total Current Liabilities | 30.55B | 33.74B | 35.64B | 38.9B | 43.9B |
| Long-term Debt | 4.69B | 3.85B | 4.58B | 7.82B | 6.86B |
| Deferred Tax Liabilities | 3.02B | 3.14B | 3.09B | 2.43B | 2.31B |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 5.89B | 5.14B | 4.55B | 5.8B | 5.95B |
| Total Non-current Liabilities | 14.03B | 12.57B | 12.69B | 16.86B | 16.12B |
| Total Liabilities | 44.58B | 46.31B | 48.33B | 55.76B | 60.02B |
| Common Stock | 2.81B | 2.75B | 2.92B | 2.96B | 2.89B |
| Retained Earnings | (280M) | (642M) | (286M) | 783M | 2.01B |
| Accumulated OCI | (114M) | (151M) | (167M) | (155M) | (165M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 3M | 1M | 1M | 147M | 159M |
| Total Equity | (706M) | (2.96B) | (3.21B) | (2.63B) | (2.72B) |
| Total Debt | 5.81B | 5.18B | 5.61B | 9.35B | 9.95B |
| Net Debt | 1.09B | 1.1B | 476M | 5.47B | 5.09B |
Cardinal Health, Inc.
NYSE:CAH
Intrinsic Alpha fair value
Locked
Current Price
$278.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.